LAWRENCE, Mass., May 25, 2017 /PRNewswire/ -- NxStage
Medical, Inc. (Nasdaq: NXTM), a leading medical technology company
focused on advancing renal care, today announced that Jeffrey H. Burbank, Chief Executive Officer,
plans to participate in the following schedule of investor
conferences. Where applicable, a webcast of the event will be made
available at http://ir.nxstage.com/.
Jefferies Healthcare Conference
NY, NY
Wednesday, June 7, 2017
4:30 p.m. ET
William Blair Growth Stock Conference
Chicago, IL
Wednesday, June 14, 2017
8:40 a.m. C.S.T.
About NxStage
NxStage Medical, Inc. (Nasdaq: NXTM) is a leading medical
technology company, headquartered in Lawrence, Massachusetts, USA, that develops,
manufactures and markets innovative products for the treatment of
end-stage renal disease (ESRD) and acute kidney failure. NxStage
has also established a small number of dialysis clinics committed
to the development of innovative care delivery models for patients
with ESRD. For more information on NxStage and its products and
services, please visit the Company's website at
http://www.nxstage.com and www.nxstagekidneycare.com.
Forward-Looking Statements
This release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
All statements contained in this release that are not clearly
historical in nature are forward-looking, and the words
"anticipate," "believe," "expect," "estimate," "plan," and similar
expressions are generally intended to identify forward-looking
statements. Examples of these forward-looking statements include
statements as to Mr. Burbank's plans to present at these
conferences. NxStage specifically disclaims any obligation to
update these forward-looking statements. These forward-looking
statements should not be relied upon as representing NxStage's
expectations or beliefs as of any date subsequent to the date of
this press release.
Contact:
Kristen K. Sheppard, Esq.
Investor Relations
ksheppard@nxstage.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nxstage-announces-second-quarter-2017-investor-conference-schedule-300463179.html
SOURCE NxStage Medical, Inc.